Atox Bio
Homepage http://www.atoxbio.com
LinkedIn Profile https://linkedin.com/company/at***-bi***
HQ Location
United States , North Carolina, Chapel HillChapel Hill, NC, USA
Atox Bio is a late stage biotechnology company that develops novel immunomodulators to treat critically ill patients.
Initial focus is on patients with Necrotizing Soft Tissue Infections (“flesh eating bacteria”), a rare, life threatening, infection for which no current therapy exists.
AB103, the company’s lead product, is studied in ACCUTE (AB103 Clinical Composite endpoint StUdy in necrotizing soft Tissue InfEctions), a phase 3 clinical trial.
AB103 received Orphan Drug designation from the FDA and EMA and Fast Track designation from the FDA.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Atox Bio
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Employees of 'Atox Bio'
Decision makers at Atox Bio
5 Decision Makers at Atox Bio
Purchasing & operations at Atox Bio
7 Purchasing & Operations at Atox Bio
Information technology at Atox Bio
2 Information Technology at Atox Bio
Details of Atox Bio
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
